As cell and gene therapies continue to advance, so too do the regulatory frameworks that surround these products. Researchers and industry organisations can find navigating the regulatory guidelines a challenge as they endeavour to interpret legal and safety protocols, and seek to understand the geographical variations and unique challenges that exist in different regions, while facilitating product development.
In this BioBriefing, ERA Consulting will take both seasoned tourists and novices alike on a guided tour of the established concepts, current regulatory landscapes, and more recent destinations being explored by product development teams in the cell and gene therapy space. ERA will provide attendees with an insight into some of the trending hot topics in cell & gene therapies and will explore the opportunities and challenges that lie ahead for organisations in the industry.
Who should attend:
R&D scientists, biotech entrepreneurs, industry related professionals, doctoral students and post-doctoral scientists.
For a more in-depth look at this topic, you may be interested in participating in Module 6 of our Going Global Program – Navigating cell and gene therapies through global regulatory pathways.
Date: Tuesday 13 August
Time: 3.45 pm registration, presentation & discussion 4.00 pm – 5.00 pm, followed by networking until 6.00 pm
Venue: Allens, 37/101 Collins Street, Melbourne
BioMelbourne Network Members: $65
Non Members: $130
(Prices include GST.)
Note: Participants registered for the Going Global program will receive three registrations for this event.
A full refund is given up to 7 days prior to the event. No refunds within 7 days of the event.